Changes in the nasal carriage of drug-resistant Streptococcus pneumoniae in urban and rural Vietnamese schoolchildren

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 5, 2007, Pages 484-492

  Schultsz, Constance ^a   Vien, Le Minh ^a   Campbell, James I ^a   Chau, Nguyen Van Vinh ^b   Diep, To Song ^b   Hoang, Nguyen Van Minh ^a   Nga, Tran Thi Thu ^a   Savelkoul, Paul ^c   Stepnieuwska, Kasia ^a   Parry, Christopher ^d   Hien, Tran Tinh ^b   Farrar, Jeremy J ^a  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Antimicrobials; Drug resistance; Rural population; Streptococcus pneumoniae; Urban population; Vietnam

Indexed keywords

ASPARAGINE; CEFTRIAXONE; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LYSINE; PENICILLIN G; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NASOPHARYNX; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; RURAL AREA; STREPTOCOCCUS PNEUMONIAE; SUBURBAN AREA; URBAN AREA; VIET NAM;

STREPTOCOCCUS PNEUMONIAE;

EID: 33847727747     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2006.08.010     Document Type: Article

References (39)

1. Arason V.A., Gunnlaugsson A., Sigurdsson J.A., Erlendsdottir H., Gudmundsson S., and Kristinsson K.G. Clonal spread of resistant pneumococci despite diminished antimicrobial use. Microb. Drug Resist. 8 (2002) 187-192
2. Bartoloni A., Bartalesi F., Mantella A., Dell'Amico E., Roselli M., Strohmeyer M., Barahona H.G., Barron V.P., Paradisi F., and Rossolini G.M. High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption. J. Infect. Dis. 189 (2004) 1291-1294
3. Bogaert D., Ha N.T., Sluijter M., Lemmens N., De Groot R., and Hermans P.W. Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam. J. Clin. Microbiol. 40 (2002) 3903-3908
4. Chiou C.C., Liu Y.C., Huang T.S., Hwang W.K., Wang J.H., Lin H.H., Yen M.Y., and Hsieh K.S. Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan. J. Clin. Microbiol. 36 (1998) 1933-1937
5. Clinical and Laboratory Standards Institute, 2003. Performance standards for antimicrobial susceptibility testing. Thirteenth Information Supplement. CLSI, Wayne, PA.
6. Davies T.A., Evangelista A., Pfleger S., Bush K., Sahm D.F., and Goldschmidt R. Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000. Antimicrob. Agents Chemother. 46 (2002) 119-124
7. De Lencastre H., and Tomasz A. From ecological reservoir to disease: the nasopharynx, day-care centres and drug-resistant clones of Streptococcus pneumoniae. J. Antimicrob. Chemother. 50 Suppl. S2 (2002) 75-81
8. Enright M.C., and Spratt B.G. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144 (1998) 3049-3060
9. Feil E.J., Li B.C., Aanensen D.M., Hanage W.P., and Spratt B.G. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186 (2004) 1518-1530
10. Goldstein E.J., and Garabedian-Ruffalo S.M. Widespread use of fluoroquinolones versus emerging resistance in pneumococci. Clin. Infect. Dis. 35 (2002) 1505-1511
11. Gonzalez B.E., Hulten K.G., Lamberth L., Kaplan S.L., and Mason Jr. E.O. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr. Infect. Dis. J. 25 (2006) 301-305
12. Ho P.L., Yung R.W., Tsang D.N., Que T.L., Ho M., Seto W.H., Ng T.K., Yam W.C., and Ng W.W. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J. Antimicrob. Chemother. 48 (2001) 659-665
13. Ho P.L., Yam W.C., Que T.L., Tsang D.N., Seto W.H., Ng T.K., and Ng W.S. Target site modifications and efflux phenotype in clinical isolates of Streptococcus pneumoniae from Hong Kong with reduced susceptibility to fluoroquinolones. J. Antimicrob. Chemother. 47 (2001) 655-658
14. Hunt Gerardo S., Citron D.M., Claros M.C., and Goldstein E.J. Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. Antimicrob. Agents Chemother. 40 (1996) 2413-2415
15. Ip M., Lyon D.J., Yung R.W., Tsang L., and Cheng A.F. Introduction of new clones of penicillin-nonsusceptible Streptococcus pneumoniae in Hong Kong. J. Clin. Microbiol. 40 (2002) 1522-1525
16. Jorgensen J.H., Ferraro M.J., McElmeel M.L., Spargo J., Swenson J.M., and Tenover F.C. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J. Clin. Microbiol. 32 (1994) 159-163
17. Klugman K.P. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect. Dis. 1 (2001) 85-91
18. Klugman K.P., and Lonks J.R. Hidden epidemic of macrolide-resistant pneumococci. Emerg. Infect. Dis. 11 (2005) 802-807
19. Larsson M., Kronvall G., Chuc N.T., Karlsson I., Lager F., Hanh H.D., Tomson G., and Falkenberg T. Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community. Trop. Med. Int. Health 5 (2000) 711-721
20. Lee N.Y., Song J.H., Kim S., Peck K.R., Ahn K.M., Lee S.I., Yang Y., Li J., Chongthaleong A., Tiengrim S., Aswapokee N., Lin T.Y., Wu J.L., Chiu C.H., Lalitha M.K., Thomas K., Cherian T., Perera J., Yee T.T., Jamal F., Warsa U.C., Van P.H., Carlos C.C., Shibl A.M., Jacobs M.R., and Appelbaum P.C. Carriage of antibiotic-resistant pneumococci among Asian children: a multinational surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP). Clin. Infect. Dis. 32 (2001) 1463-1469
21. Lim S., Bast D., McGeer A., de Azavedo J., and Low D.E. Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance. Emerg. Infect. Dis. 9 (2003) 833-837
22. Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin. Infect. Dis. 32 (2001) 1044-1054
23. Macias E.A., Mason Jr. E.O., Ocera H.Y., and LaRocco M.T. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J. Clin. Microbiol. 32 (1994) 430-432
24. Morrissey I., Farrell D.J., Bakker S., Buckridge S., and Felmingham D. Molecular characterization and antimicrobial susceptibility of fluoroquinolone-resistant or -susceptible Streptococcus pneumoniae from Hong Kong. Antimicrob. Agents Chemother. 47 (2003) 1433-1435
25. Oh W.S., Suh J.Y., Song J.H., Ko K.S., Jung S.I., Peck K.R., Lee N.Y., Yang Y., Chongthaleong A., Chiu C.H., Kamarulzaman A., Parasakthi N., Lalitha M.K., Perera J., Yee T.T., Kumarasinghe G., and Carlos C.C. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study. Microb. Drug Resist. 10 (2004) 37-42
26. Okeke I.N., Laxminarayan R., Bhutta Z.A., Duse A.G., Jenkins P., O'Brien T.F., Pablos-Mendez A., and Klugman K.P. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect. Dis. 5 (2005) 481-493
27. Parry C.M., Diep T.S., Wain J., Houa N.T.T., Gainsborough M., Nga D., Davies C., Phu N.H., Hien T.T., White N.J., and Farrar J.J. Nasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agents. Antimicrob. Agents Chemother. 44 (2000) 484-488
28. 23F-1 clone. Antimicrob. Agents Chemother. 46 (2002) 3512-3517
29. Porat N., Arguedas A., Spratt B.G., Trefler R., Brilla E., Loaiza C., Godoy D., Bilek N., and Dagan R. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J. Infect. Dis. 190 (2004) 2154-2161
30. Porat N., Barkai G., Jacobs M.R., Trefler R., and Dagan R. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J. Infect. Dis. 189 (2004) 385-392
31. Quagliarello A.B., Parry C.M., Hien T.T., and Farrar J.J. Factors associated with carriage of penicillin-resistant Streptococcus pneumoniae among Vietnamese children: a rural-urban divide. J. Health Popul. Nutr. 21 (2003) 316-324
32. Samore M.H., Magill M.K., Alder S.C., Severina E., Morrison-De Boer L., Lyon J.L., Carroll K., Leary J., Stone M.B., Bradford D., Reading J., Tomasz A., and Sande M.A. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 108 (2001) 856-865
33. Savelkoul P.H., Aarts H.J., de Haas J., Dijkshoorn L., Duim B., Otsen M., Rademaker J.L., Schouls L., and Lenstra J.A. Amplified-fragment length polymorphism analysis: the state of an art. J. Clin. Microbiol. 37 (1999) 3083-3091
34. Schurek K.N., Adam H.J., Siemens C.G., Hoban C.J., Hoban D.J., and Zhanel G.G. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003. J. Antimicrob. Chemother. 56 (2005) 769-772
35. Smith H.J., Noreddin A.M., Siemens C.G., Schurek K.N., Greisman J., Hoban C.J., Hoban D.J., and Zhanel G.G. Designing fluoroquinolone breakpoints for Streptococcus pneumoniae by using genetics instead of pharmacokinetics-pharmacodynamics. Antimicrob. Agents Chemother. 48 (2004) 3630-3635
36. Song J.H., Jung S.I., Ko K.S., Kim N.Y., Son J.S., Chang H.H., Ki H.K., Oh W.S., Suh J.Y., Peck K.R., Lee N.Y., Yang Y., Lu Q., Chongthaleong A., Chiu C.H., Lalitha M.K., Perera J., Yee T.T., Kumarasinghe G., Jamal F., Kamarulzaman A., Parasakthi N., Van P.H., Carlos C., So T., Ng T.K., and Shibl A. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob. Agents Chemother. 48 (2004) 2101-2107
37. Tenover F.C., Baker C.N., and Swenson J.M. Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae. J. Clin. Microbiol. 34 (1996) 10-14
38. Walson J.L., Marshall B., Pokhrel B.M., Kafle K.K., and Levy S.B. Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu. J. Infect. Dis. 184 (2001) 1163-1169
39. Watanabe H., Asoh N., Hoshino K., Watanabe K., Oishi K., Kositsakulchai W., Sanchai T., Kunsuikmengrai K., Kahintapong S., Khantawa B., Tharavichitkul P., Sirisanthana T., and Nagatake T. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae and molecular characterization of multidrug-resistant serotype 19F, 6B, and 23F pneumococci in northern Thailand. J. Clin. Microbiol. 41 (2003) 4178-4183